Dynamic International Prognostic Scoring System scores, pre-transplant therapy and chronic graft-versus-host disease determine outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis. - Wikidata - awgldk - TriplyDB

Dynamic International Prognostic Scoring System scores, pre-transplant therapy and chronic graft-versus-host disease determine outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis.

Dynamic International Prognostic Scoring System scores, pre-transplant therapy and chronic graft-versus-host disease determine outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis.

http://www.wikidata.org/entity/Q33400683

about

Hematopoietic Cell Transplantation as Curative Therapy for Patients with Myelofibrosis: Long-Term Success in all Age Groups Managing patients with myelofibrosis and low platelet counts.Allogeneic hematopoietic stem cell transplantation in patients with polycythemia vera or essential thrombocythemia transformed to myelofibrosis or acute myeloid leukemia: a report from the MPN Subcommittee of the Chronic Malignancies Working Party o MPD-RC 101 prospective study of reduced-intensity allogeneic hematopoietic stem cell transplantation in patients with myelofibrosis Role of hematopoietic stem cell transplantation in patients with myeloproliferative disease.Janus kinase inhibitors and allogeneic stem cell transplantation for myelofibrosis JAK2 p.V617F allele burden in myeloproliferative neoplasms one month after allogeneic stem cell transplantation significantly predicts outcome and risk of relapse.Reduced-intensity hematopoietic cell transplantation for patients with primary myelofibrosis: a cohort analysis from the center for international blood and marrow transplant research.Allogeneic hematopoietic cell transplantation for myelofibrosis in the era of JAK inhibitors.Myelofibrosis: an update on current pharmacotherapy and future directions.Allogeneic transplantation for myelofibrosis: for whom, when, and what are the true benefits?Allo-SCT for myelofibrosis: reversing the chronic phase in the JAK inhibitor era?Current Challenges in Stem Cell Transplantation in Myelofibrosis.Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group.Allogeneic hematopoietic stem cell transplantation for myelofibrosis and chronic myelomonocytic leukemia.Early and Late Complications in Patients with Allogeneic Transplantation of Hematopoietic Stem Cell - Case Report.Effect of conditioning regimens on graft failure in myelofibrosis: a retrospective analysis.Novel Therapies for Myelofibrosis.

P2860

Q26786893-6B915E5F-80F1-4244-854C-C58B14693FCD Q33432406-157BF944-8560-41AC-9D03-E65186CDB68D Q33558748-A1094882-56BA-4E4F-B5DF-1C22094D7DE2 Q34047897-38C55F1D-F88D-4479-B0D8-FBC96D61F43F Q34625390-B08BCC17-AB84-4E65-A61D-B0B26E17E621 Q35735663-1E734AC8-AE1A-4338-8532-CABEC62FB3B8 Q36805838-93FB6E5B-F1D1-46B4-9E3A-A45AD3F73768 Q37457111-2709A8AA-B2B2-4427-B15A-694C40EB8368 Q38018908-BF538BFF-F94D-49FC-B6CB-9BA8A110AEA1 Q38091447-EDBC5EDA-DD6C-4AE9-B55E-1534EF034D54 Q38174781-903FF6D2-0051-4477-9D87-54C5C1216CD7 Q38349213-33E781F7-4FCB-4DBD-9FB7-95BA8CEA9EE6 Q38569146-C5F3AB6F-8023-4B6A-ACE9-E4548C981EA3 Q38570614-0A5435AF-DDC4-42B0-8E5A-9DE540CCD1CA Q38603384-BD13B9AE-4638-4F79-82D4-6D6C9ABFA4A6 Q40138864-43EC3B70-66EA-4977-865D-13AB78BC3B9D Q41519713-4D861FBF-BDE5-4B82-9019-A7517929F46D Q52817185-80D166B6-D4A8-4210-AE2B-45BD887C6D43

P2860

Dynamic International Prognostic Scoring System scores, pre-transplant therapy and chronic graft-versus-host disease determine outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis.

http://www.wikidata.org/entity/Q33400683

description

2012 nî lūn-bûn

@nan

2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Dynamic International Prognost ...... splantation for myelofibrosis.

@ast

Dynamic International Prognost ...... splantation for myelofibrosis.

@en

type

label

Dynamic International Prognost ...... splantation for myelofibrosis.

@ast

Dynamic International Prognost ...... splantation for myelofibrosis.

@en

prefLabel

Dynamic International Prognost ...... splantation for myelofibrosis.

@ast

Dynamic International Prognost ...... splantation for myelofibrosis.

@en

P1433

Q33400683-EF404B7A-62C8-434A-898E-2DBC098197D8

P1476

Q33400683-D56BF7EB-B984-4051-9CD9-EDD242FC183A

P2093

Q33400683-29A655E6-4E1D-4613-A3F1-48B890859E6F

Q33400683-44B9132E-F4A5-4A1C-AAD9-6B65AD8D72DE

Q33400683-767BC158-A985-47A4-9308-BC13ECBF30A1

Q33400683-A14BCAD9-F9E8-41F5-B3A6-B8ADC2E23B60

Q33400683-A912341B-AF19-42DF-B6D6-1DEF9F4A522E

Q33400683-DBBF6FE1-CD5C-4663-B9A7-338B52F865CC

Q33400683-E7386B3B-B6F0-4CAF-B38A-4A5F5A7C3425

P2860

Q33400683-1DDBCFEC-52DF-4D69-83E8-66DCCEB7BDA8

Q33400683-2C845BAD-4E56-4771-BE2C-8B5661FE67CD

Q33400683-2E03A849-499D-4CF1-A9E0-FF77E166B77A

Q33400683-32695677-FAC9-44C5-974C-EF8E0DA29FDD

Q33400683-3AE9BECF-8ABB-4DB0-B2B7-392AB8B97E42

Q33400683-3D246F4E-0703-4E0A-9DA5-4721A292BA65

Q33400683-49127D44-FD09-47D3-A7CB-610D0CF197FA

Q33400683-8318F8E9-E854-4A50-940C-7DD342C7B457

Q33400683-84DAA228-BA9C-4ECE-A4CC-9810EB536E36

Q33400683-85BAD3D6-2E5F-4435-9220-C01B0F0A27CC

P304

Q33400683-7DD4AF61-B703-443F-9EF8-A72D48A6DF81

P31

Q33400683-2B3B5B4A-7EF9-41A7-AC6E-B683EDEDADA6

P356

Q33400683-E179A6AE-AD15-407F-856C-CFDD0813E477

P433

Q33400683-8CB69593-3BE0-4FA1-B759-3B94D9693D5A

P478

Q33400683-C1CC2EC7-E06E-48F2-9764-F0AB364673BD

P577

Q33400683-F02052BE-DE3F-49C8-838A-B103BC24B97D

P5875

Q33400683-4C9E56B9-BBF3-4A5C-9490-9B6235342716

P698

Q33400683-6C0C3B71-1E95-4B58-A73A-205E47487AF9

P932

Q33400683-66B3E37F-69DD-42D1-90F1-958643AD2CDA

P356

HAEMATOL.2011.061168

P1433

P1476

Dynamic International Prognost ...... splantation for myelofibrosis.

@en

P2093

Ahmet H Elmaagacli

http://www.w3.org/2001/XMLSchema#string

Dietrich W Beelen

http://www.w3.org/2001/XMLSchema#string

Markus Ditschkowski

http://www.w3.org/2001/XMLSchema#string

Michael Koldehoff

http://www.w3.org/2001/XMLSchema#string

Nina K Steckel

http://www.w3.org/2001/XMLSchema#string

Rudolf Trenschel

http://www.w3.org/2001/XMLSchema#string

Tanja Gromke

http://www.w3.org/2001/XMLSchema#string

P2860

Phenotypic variations and new mutations in JAK2 V617F-negative polycythemia vera, erythrocytosis, and idiopathic myelofibrosis

A gain-of-function mutation of JAK2 in myeloproliferative disorders

Allogeneic haematopoietic stem cell transplantation for myelofibrosis: a report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).

DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status.

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators.

Outcome of transplantation for myelofibrosis.

Primary myelofibrosis (PMF), post polycythemia vera myelofibrosis (post-PV MF), post essential thrombocythemia myelofibrosis (post-ET MF), blast phase PMF (PMF-BP): Consensus on terminology by the international working group for myelofibrosis resear

Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNet.

Chronic graft-versus-host disease and other late complications of bone marrow transplantation.

1994 Consensus Conference on Acute GVHD Grading

P304

1574-1581

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3324/HAEMATOL.2011.061168

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

97

http://www.w3.org/2001/XMLSchema#string

P577

2012-04-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

223973185

http://www.w3.org/2001/XMLSchema#string

P698

22491742

http://www.w3.org/2001/XMLSchema#string

P932

3487559

http://www.w3.org/2001/XMLSchema#string